Coursera (NYSE:COUR) reported quarterly sales of $136.40 million which beat the analyst consensus estimate of $128.31 million by 6.31 percent. This is a 24.14 percent increase over sales of $109.88 million the same period last year.
What’s Going On With Medical Therapeutic Firm Aethlon Medical On Friday?
Aethlon Medical unveils results in removing extracellular vesicles (EVs) from plasma. Preclinical evidence supports upcoming phase 1 trials for solid tumor patients undergoing anti-PD-1 monotherapy.